Zeria Will Launch FD Treatment in June, Finding Patients Key, President Ibe Says

Sachiaki Ibe, President, Zeria Pharmaceutical Zeria Pharmaceutical will launch the world’s first functional dyspepsia (FD) treatment Acofide (acotiamide HCl hydrate) in June, President Sachiaki Ibe said at an earnings conference on May 17. “Experts are giving Acofide high marks, and...read more